The goal of the present study was to evaluate the effects of medication reminders via the BreatheMate device on adherence in patients with COPD.


 Patients in the intervention (n = 68) and control (n = 70) groups received the BreatheMate device, smartphone application, and vouchers to redeem pressurized metered-dose inhalers (pMDIs) for the prescribed 2 puffs of budesonide/formoterol 160/4.5 μg twice daily.  Medication reminders through the BreatheMate device and application produced greater adherence to inhaled therapy in patients with COPD.
BreatheMate
Patients in the intervention (n = 68) and control (n = 70) groups received the BreatheMate device, smartphone application, and vouchers to redeem pressurized metered-dose inhalers (pMDIs) for the prescribed 2 puffs of budesonide/formoterol 160/4.5 μg twice daily. 
smartphone application